Articles tagged as 'covid-19'

10 results

COVID-19 top priority for research team
Check in with UMC’s head of pharmacovigilance science to catch up with her team’s current research priorities.


Pharmacovigilance in the age of COVID-19
COVID-19 is one of the most disruptive events in history and a threat to public health. In the rush for treatments and vaccines, how do we keep sight of the need to ensure safety?


Reflecting on the lessons of a past pandemic – A career comes full circle
At the end of an eventful career, UMC’s retiring chief medical officer, reflects on how the lessons of the H1N1 pandemic helped prepare the pharmacovigilance world for COVID-19.


New film goes behind the scenes of UMC’s pandemic operations
A new short film captures UMC's work to support the pharmacovigilance community as it prepares to take on COVID-19. Filmmaker Matthew Barwick explains the thinking behind it.


VigiFlow boosts vaccine surveillance efforts
Multiple COVID-19 vaccines came sooner than expected. But the key systems needed for reporting suspected side effects are up and running to support efficient safety monitoring.


New podcast episode – Into the infodemic
Tune in to the latest in our Drug Safety Matters Long Reads series, exploring how pharmacovigilance experts can help win the war on viral misinformation – by not fighting it.


Substandard and Falsified COVID-19 Vaccines in the Americas: Can vaccine equity help?
COVID-19 vaccinations are picking up speed in wealthy countries. But for lower-income countries, does poor equity of access raise the risk of compromised products?


Into the infodemic: Countering COVID's medicine myths
As the COVID-19 pandemic spread around the world, so did wave of viral misinformation. For pharmacovigilance, fighting the “infodemic” is a massive, but necessary, battle.


Interesting times indeed for Europe’s top medicines regulator
There was no chance the new head of the European Union’s medicines regulator could simply ease into the job. Emer Cooke, had Brexit and a pandemic on her desk from day one.


Record growth pushes VigiBase past 28 million reports
After decades of slow but steady growth, VigiBase has recently entered a new phase of accelerating expansion, driven by a range of converging forces.


Our website uses cookies

Cookies are small text files held on your computer. They allow us to give you the best browsing experience possible and mean that we can understand how you use our site. Some cookies have already been set. You can delete and block cookies but parts of our site won't work without them. By using our website you accept our use of cookies.

Find out more